Science & Technology
Sbir Phase I (Nimh Topic 3): Point-of-Care and Pharmacy-Based Antiretroviral Drug Adherence Assays - Point-of-Care Anti-Retroviral Drug Adherence Impedance Spectroscopy Device
Department of Health and Human Services — National Institutes of Health
Opportunity #: 75N95025C00009
Award Ceiling
$307K
Award Floor
$307K
Close Date
N/A
Total Funding
$307K
Expected Awards
1
Cost Sharing Required
No
Grants.gov ID
sbir-75N95025C00009
Description
SBIR Phase Phase I award: "SBIR PHASE I (NIMH TOPIC 3): POINT-OF-CARE AND PHARMACY-BASED ANTIRETROVIRAL DRUG ADHERENCE ASSAYS - POINT-OF-CARE ANTI-RETROVIRAL DRUG ADHERENCE IMPEDANCE SPECTROSCOPY DEVICE" awarded to GUILD ASSOCIATES INC in DUBLIN, Ohio. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $306,718. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.